Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 454-461

  Sanders Jr , W Eugene ^a   Tenney, James H ^b   Kessler, Robert E ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CLINICAL ARTICLE; DRUG EFFICACY; ENTEROBACTER; FEMALE; HUMAN; MALE; MULTIDRUG RESISTANCE; PNEUMONIA; PRIORITY JOURNAL; URINARY TRACT INFECTION;

EID: 0006884507     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.454     Document Type: Article

References (12)

1. Kessler RE, Bies M, Buck RE, et al. Comparison of a new cephalosporin, BMY28142, with other broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother 1985;27:207-16.
2. Sanders CC. Cefepime: the next generation? Clin Infect Dis 1993;17: 369-79.
3. Sanders CC, Moland ES. Cefepime: the last generation or the first enhanced-potency broad-spectrum cephalosporin? Clin Drug Invest 1995; 10:369-79.
4. Marchou B, Michea-Hamzehpour M, Lucain C, Pechère J-C. Development of β-lactam-resistant Enterobacter cloacae in mice. J Infect Dis 1987; 156:344-54.
5. van Ogtrop ML, Buiot HFL, Mattie H, et al. Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins. Antimicrob Agents Chemother 1991;35:976-82.
6. Sanders CC. β-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992;14:1089-99.
7. Ehrhardt AF, Sanders CC. β-Lactam resistance amongst Enterobacter species. J Antimicrob Chemother 1993;32(suppl B):1-11.
8. Sanders CC, Sanders WE Jr. β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824-39.
9. Gaston MA. Enterobacter: an emerging nosocomial pathogen. J Hosp Infect 1988;11:197-208.
10. Johnson MP, Ramphal R. β-Lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis 1990; 162:981-3.
11. Bodey GP, Elting LS, Rodriguez S. Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital. Rev Infect Dis 1991;13: 550-8.
12. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-90.